Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

NCT00898014 · clinicaltrials.gov ↗

COMPLETED

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

GENETIC: fluorescence in situ hybridization
OTHER: immunologic technique
OTHER: laboratory biomarker analysis

Sponsor

Institut Curie